Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neutralization of SARS-CoV-2 Omicron sub-lineages BA.1, BA.1.1, and BA.2
John P. Evans, Cong Zeng, Panke Qu, et al.
Cell Host & Microbe (2022) Vol. 30, Iss. 8, pp. 1093-1102.e3
Open Access | Times Cited: 128

Showing 26-50 of 128 citing articles:

Neutralization and Stability of JN.1-derived LB.1, KP.2.3, KP.3 and KP.3.1.1 Subvariants
Pei Li, Julia N. Faraone, Cheng Chih Hsu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 7
Neutralization of the SARS-CoV-2 Deltacron and BA.3 Variants
John P. Evans, Panke Qu, Cong Zeng, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 24, pp. 2340-2342
Open Access | Times Cited: 32
BNT162b2-induced neutralizing and non-neutralizing antibody functions against SARS-CoV-2 diminish with age
Timothy A. Bates, Pei Lu, Ye jin Kang, et al.
Cell Reports (2022) Vol. 41, Iss. 4, pp. 111544-111544
Open Access | Times Cited: 29
Effectiveness and durability of BNT162b2 vaccine against hospital and emergency department admissions due to SARS-CoV-2 omicron sub-lineages BA.1 and BA.2 in a large health system in the USA: a test-negative, case-control study
Sara Y. Tartof, Jeff Slezak, Laura Puzniak, et al.
The Lancet Respiratory Medicine (2022) Vol. 11, Iss. 2, pp. 176-187
Open Access | Times Cited: 28
Key mutations in the spike protein of SARS‐CoV‐2 affecting neutralization resistance and viral internalization
Qiong Wang, Sheng‐Bao Ye, Zhijian Zhou, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 28
SARS-CoV-2 Omicron BA.1 breakthrough infection drives late remodeling of the memory B cell repertoire in vaccinated individuals
Aurélien Sokal, Giovanna Barba‐Spaeth, Lise Hunault, et al.
Immunity (2023) Vol. 56, Iss. 9, pp. 2137-2151.e7
Open Access | Times Cited: 20
Continued evasion of neutralizing antibody response by Omicron XBB.1.16
Julia N. Faraone, Panke Qu, Yi-Min Zheng, et al.
Cell Reports (2023) Vol. 42, Iss. 10, pp. 113193-113193
Open Access | Times Cited: 19
Durability and breadth of neutralisation following multiple antigen exposures to SARS-CoV-2 infection and/or COVID-19 vaccination
Alexander P. Underwood, Christina Sølund, Carlota Fernandez-Antunez, et al.
EBioMedicine (2023) Vol. 89, pp. 104475-104475
Open Access | Times Cited: 16
Discovery of novel papain-like protease inhibitors for potential treatment of COVID-19
Fatema Hersi, Anusha Sebastian, Hamadeh Tarazi, et al.
European Journal of Medicinal Chemistry (2023) Vol. 254, pp. 115380-115380
Open Access | Times Cited: 16
Omicron BQ.1.1 and XBB.1 unprecedentedly escape broadly neutralizing antibodies elicited by prototype vaccination
Bin Ju, Qing Fan, Congcong Liu, et al.
Cell Reports (2023) Vol. 42, Iss. 6, pp. 112532-112532
Open Access | Times Cited: 16
An ancestral SARS-CoV-2 vaccine induces anti-Omicron variants antibodies by hypermutation
Seoryeong Park, Jaewon Choi, Yonghee Lee, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Nonhuman primate antigenic cartography of SARS-CoV-2
Annika Rössler, Antonia Netzl, Ninaad Lasrado, et al.
Cell Reports (2025) Vol. 44, Iss. 1, pp. 115140-115140
Open Access
Lessons Learnt from COVID-19: Computational Strategies for Facing Present and Future Pandemics
Matteo Pavan, Stefano Moro
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4401-4401
Open Access | Times Cited: 13
Single-epitope T cell–based vaccine protects against SARS-CoV-2 infection in a preclinical animal model
Takuya Tada, Ju-Yi Peng, Belinda M. Dcosta, et al.
JCI Insight (2023) Vol. 8, Iss. 7
Open Access | Times Cited: 13
Mutations of SARS-CoV-2 and their impact on disease diagnosis and severity
Laiali Alquraan, Karem H. Alzoubi, Suzie Yaseen Rababa'h
Informatics in Medicine Unlocked (2023) Vol. 39, pp. 101256-101256
Open Access | Times Cited: 13
Challenges and Prospects in Developing Future SARS-CoV-2 Vaccines: Overcoming Original Antigenic Sin and Inducing Broadly Neutralizing Antibodies
John P. Evans, Shan‐Lu Liu
The Journal of Immunology (2023) Vol. 211, Iss. 10, pp. 1459-1467
Open Access | Times Cited: 13
Genomic surveillance of SARS‐CoV‐2 strains circulating in Iran during six waves of the pandemic
Kaveh Sadeghi, Sevrin Zadheidar, Arghavan Zebardast, et al.
Influenza and Other Respiratory Viruses (2023) Vol. 17, Iss. 4
Open Access | Times Cited: 12
Efficacy of Licensed Monoclonal Antibodies and Antiviral Agents against the SARS-CoV-2 Omicron Sublineages BA.1 and BA.2
Lia Fiaschi, Filippo Dragoni, Elisabetta Schiaroli, et al.
Viruses (2022) Vol. 14, Iss. 7, pp. 1374-1374
Open Access | Times Cited: 21
Post-Vaccination Neutralization Responses to Omicron Sub-Variants
Henning Jacobsen, Maeva Katzmarzyk, Melissa M. Higdon, et al.
Vaccines (2022) Vol. 10, Iss. 10, pp. 1757-1757
Open Access | Times Cited: 21
Differential Evasion of Delta and Omicron Immunity and Enhanced Fusogenicity of SARS-CoV-2 Omicron BA.4/5 and BA.2.12.1 Subvariants
Panke Qu, Julia N. Faraone, John P. Evans, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 19
Neutralization sensitivity, fusogenicity, and infectivity of Omicron subvariants
Xuejun Wang, Lin Yao, Hong‐Yun Zhang, et al.
Genome Medicine (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 19
Modular adjuvant-free pan-HLA-DR-immunotargeting subunit vaccine against SARS-CoV-2 elicits broad sarbecovirus-neutralizing antibody responses
Audrey Kassardjian, Eric Sun, Jamie Sookhoo, et al.
Cell Reports (2023) Vol. 42, Iss. 4, pp. 112391-112391
Open Access | Times Cited: 11
The XBB.1.5 slightly increase the binding affinity for host receptor ACE2 and exhibit strongest immune escaping features: molecular modeling and free energy calculation
Muhammad Suleman, Aneela Murtaza, Haji Muhammad Shoaib Khan, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 11
Immune imprinting as a barrier to effective COVID-19 vaccines
Julia N. Faraone, Shan‐Lu Liu
Cell Reports Medicine (2023) Vol. 4, Iss. 11, pp. 101291-101291
Open Access | Times Cited: 11
Identification of a broad-spectrum high-affinity peptide ligand for the purification of spike proteins
Mengke Hu, Xiaoyan Dong, Qinghong Shi, et al.
Journal of Chromatography A (2024) Vol. 1723, pp. 464912-464912
Closed Access | Times Cited: 3

Scroll to top